Product Information |
Synonym(s) |
GSK961081, TD-5959 |
Chemical Name |
(R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
Application |
Batefenterol is a muscarinic receptor antagonist and β2-adrenoceptor agonist |
CAS Number |
743461-65-6 |
Purity |
≥98.0% |
Molecular Weight |
740.24 |
Molecular Formula |
C₄₀H₄₂ClN₅O₇ |
SMILES |
O=C(OC1CCN(CCC(NC2=CC(OC)=C(CNC[C@H](O)C3=CC=C(O)C4=C3C=CC(N4)=O)C=C2Cl)=O)CC1)NC5=CC=CC=C5C6=CC=CC=C6 |
Target & IC50 |
hβ2-adrenoceptor agonist: EC50 = 0.29 nM |
Solubility |
DMSO: 100 mg/mL (135.09 mM) |
Preparing Stock Solutions |
ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
1 mM |
1.3509 ml |
6.7545 ml |
13.5091 ml |
5 mM |
0.2702 ml |
1.3509 ml |
2.7018 ml |
10 mM |
0.1351 ml |
0.6755 ml |
1.3509 ml |
50 mM |
0.0270 ml |
0.1351 ml |
0.2702 ml |
|
Shipping |
Gel Pack |
Storage |
Store at -20°C |
Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |